Rokos Capital Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,140,973
| Closed | -$25.5M | – | 87 |
|
|
2024
Q2 | $25.5M | Sell |
1,140,973
-322,657
| -22% | -$7.21M | 0.16% | 34 |
|
|
2024
Q1 | $40.2M | Hold |
1,463,630
| – | – | 0.21% | 30 |
|
|
2023
Q4 | $44.6M | Buy |
1,463,630
+74,334
| +5% | +$2.27M | 0.39% | 15 |
|
|
2023
Q3 | $44.3M | Hold |
1,389,296
| – | – | 0.32% | 21 |
|
|
2023
Q2 | $56.5M | Hold |
1,389,296
| – | – | 0.55% | 15 |
|
|
2023
Q1 | $51.6M | Buy |
1,389,296
+563,233
| +68% | +$20.9M | 3.82% | 7 |
|
|
2022
Q4 | $28.4M | Buy |
826,063
+535,535
| +184% | +$18.4M | 1.24% | 9 |
|
|
2022
Q3 | $16.7M | Sell |
290,528
-41,856
| -13% | -$2.41M | 0.5% | 24 |
|
|
2022
Q2 | $16.8M | Buy |
332,384
+220,869
| +198% | +$11.2M | 0.49% | 23 |
|
|
2022
Q1 | $8.08M | Buy |
+111,515
| New | +$8.08M | 0.38% | 29 |
|